fulvestrant 250 MG in 5 ML Prefilled Syringe
- RxCUI
- 727762
- RxNorm name
- fulvestrant 250 MG in 5 ML Prefilled Syringe
- Display name
- fulvestrant 250 MG in 5 ML Prefilled Syringe
- Full name
- fulvestrant 250 MG in 5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLIGAVYX | FULVESTRANT | Avyxa Pharma, LLC | e20d8ca3-8837-4003-8b01-1ebec342062a | 2026-06-24 | Warnings, Adverse reactions | 727762 |
| fulvestrant | FULVESTRANT | Sagent Pharmaceuticals | d5ae9e07-73b0-4063-a9e4-0ffc5614c2b8 | 2026-03-05 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | GLENMARK PHARMACEUTICALS INC., USA | 99cf8b69-4c23-4886-80e9-b23e348b5bd7 | 2026-02-27 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 46086fe7-190d-4963-97bc-1fe22d36e6d2 | 2025-12-23 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Alembic Pharmaceuticals Inc. | b02915fe-6c44-48c1-aaeb-997ddc59a595 | 2025-08-18 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | BluePoint Laboratories. | 57352662-d2fa-4dce-828f-4c51e46e0b4d | 2025-07-25 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Eugia US LLC | 80b6dfe6-449d-4e2f-af90-bfbf9b04163b | 2025-07-03 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | BluePoint Laboratories | bc7b4eac-3b63-53d2-e053-2995a90ad5e7 | 2025-06-24 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Amneal Pharmaceuticals LLC | f36f19ad-f044-4dba-80b6-d074ddffcd86 | 2025-05-30 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Amneal Pharmaceuticals LLC | a51aa693-b433-4b2d-a71b-9ba029b10ce3 | 2025-04-30 | Warnings, Adverse reactions | 727762 |
| FULVESTRANT | FULVESTRANT | Accord Healthcare Inc. | b471eb51-488e-5312-e053-2a95a90a8116 | 2025-03-10 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Hikma Pharmaceuticals USA Inc. | 306c283b-9abe-4985-856b-1957f1f3af8b | 2025-02-10 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Athenex Pharmaceutical Division, LLC. | 8ed06e0e-c17b-4c71-8d03-888bcde4a638 | 2025-01-28 | Warnings, Adverse reactions | 727762 |
| FULVESTRANT | FULVESTRANT | Zydus Pharmaceuticals USA Inc. | 994edf79-20a5-4e3a-bb35-c4fe3e65acba | 2024-08-20 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Dr.Reddy's Laboratories Inc | 2fc17ba3-83c7-a2b4-8a75-6a0cb1e07682 | 2024-07-31 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Meitheal Pharmaceuticals Inc | 015fafb6-23f7-4566-9c23-386eee7b035d | 2024-06-17 | Warnings, Adverse reactions | 727762 |
| fulvestrant | FULVESTRANT | Sagent Pharmaceuticals | 0f05b699-c440-42c1-9557-46759a10ab17 | 2024-03-22 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Avenacy, Inc. | f44cffcc-8f5e-4a4c-a36e-ab946ce86266 | 2024-02-28 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Fresenius Kabi USA, LLC | fabe9bd8-ac23-4df1-a89a-223d5cd38914 | 2024-01-31 | Warnings, Adverse reactions | 727762 |
| Fulvestrant | FULVESTRANT | Sandoz Inc | 7a03f714-b109-4256-80a6-78c82127d624 | 2022-09-21 | Warnings, Adverse reactions | 727762 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 83d7a440-e904-4e36-afb5-cb02b1c919f7 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 43 | These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX ® (fulvestrant) injection, for intramuscular use Initial U.S. Approval: 2002 | 20200925 |
| 83d7a440-e904-4e36-afb5-cb02b1c919f7 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 43 | These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX ® (fulvestrant) injection, for intramuscular use Initial U.S. Approval: 2002 | 20200925 |
| 83d7a440-e904-4e36-afb5-cb02b1c919f7 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 43 | These highlights do not include all the information needed to use FASLODEX safely and effectively. See full prescribing information for FASLODEX. FASLODEX ® (fulvestrant) injection, for intramuscular use Initial U.S. Approval: 2002 | 20200925 |
| 2fc17ba3-83c7-a2b4-8a75-6a0cb1e07682 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 19 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240731 |
| 2fc17ba3-83c7-a2b4-8a75-6a0cb1e07682 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 19 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240731 |
| 2fc17ba3-83c7-a2b4-8a75-6a0cb1e07682 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 19 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240731 |
| f36f19ad-f044-4dba-80b6-d074ddffcd86 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 16 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250530 |
| f36f19ad-f044-4dba-80b6-d074ddffcd86 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 16 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250530 |
| f36f19ad-f044-4dba-80b6-d074ddffcd86 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 16 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250530 |
| b02915fe-6c44-48c1-aaeb-997ddc59a595 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 10 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250818 |
| b02915fe-6c44-48c1-aaeb-997ddc59a595 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 10 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250818 |
| b02915fe-6c44-48c1-aaeb-997ddc59a595 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 10 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250818 |
| 99cf8b69-4c23-4886-80e9-b23e348b5bd7 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 8 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20260227 |
| 99cf8b69-4c23-4886-80e9-b23e348b5bd7 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 8 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20260227 |
| 99cf8b69-4c23-4886-80e9-b23e348b5bd7 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 8 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20260227 |
| 46086fe7-190d-4963-97bc-1fe22d36e6d2 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20251223 |
| 46086fe7-190d-4963-97bc-1fe22d36e6d2 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20251223 |
| 46086fe7-190d-4963-97bc-1fe22d36e6d2 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20251223 |
| b471eb51-488e-5312-e053-2a95a90a8116 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250310 |
| b471eb51-488e-5312-e053-2a95a90a8116 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250310 |
| b471eb51-488e-5312-e053-2a95a90a8116 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250310 |
| 8ed06e0e-c17b-4c71-8d03-888bcde4a638 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250128 |
| 8ed06e0e-c17b-4c71-8d03-888bcde4a638 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250128 |
| 8ed06e0e-c17b-4c71-8d03-888bcde4a638 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250128 |
| 015fafb6-23f7-4566-9c23-386eee7b035d | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240617 |
| 015fafb6-23f7-4566-9c23-386eee7b035d | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240617 |
| 015fafb6-23f7-4566-9c23-386eee7b035d | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240617 |
| fabe9bd8-ac23-4df1-a89a-223d5cd38914 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240131 |
| fabe9bd8-ac23-4df1-a89a-223d5cd38914 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240131 |
| fabe9bd8-ac23-4df1-a89a-223d5cd38914 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 6 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240131 |
| 306c283b-9abe-4985-856b-1957f1f3af8b | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250210 |
| 306c283b-9abe-4985-856b-1957f1f3af8b | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250210 |
| 306c283b-9abe-4985-856b-1957f1f3af8b | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250210 |
| 840cd7c0-9f33-f74e-f136-de7fe899bfb4 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20211004 |
| 840cd7c0-9f33-f74e-f136-de7fe899bfb4 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20211004 |
| 840cd7c0-9f33-f74e-f136-de7fe899bfb4 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 4 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20211004 |
| 57352662-d2fa-4dce-828f-4c51e46e0b4d | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250725 |
| 57352662-d2fa-4dce-828f-4c51e46e0b4d | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250725 |
| 57352662-d2fa-4dce-828f-4c51e46e0b4d | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250725 |
| 80b6dfe6-449d-4e2f-af90-bfbf9b04163b | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250703 |
| 80b6dfe6-449d-4e2f-af90-bfbf9b04163b | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250703 |
| 80b6dfe6-449d-4e2f-af90-bfbf9b04163b | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250703 |
| bc7b4eac-3b63-53d2-e053-2995a90ad5e7 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250624 |
| bc7b4eac-3b63-53d2-e053-2995a90ad5e7 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250624 |
| bc7b4eac-3b63-53d2-e053-2995a90ad5e7 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250624 |
| 994edf79-20a5-4e3a-bb35-c4fe3e65acba | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240820 |
| 994edf79-20a5-4e3a-bb35-c4fe3e65acba | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240820 |
| 994edf79-20a5-4e3a-bb35-c4fe3e65acba | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240820 |
| 67566681-19b5-89df-2030-25df5b0cf641 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20210823 |
| 67566681-19b5-89df-2030-25df5b0cf641 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20210823 |
| 67566681-19b5-89df-2030-25df5b0cf641 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 3 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20210823 |
| 7a03f714-b109-4256-80a6-78c82127d624 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220921 |
| 7a03f714-b109-4256-80a6-78c82127d624 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220921 |
| 7a03f714-b109-4256-80a6-78c82127d624 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220921 |
| 141f439e-078c-4a59-acff-ebf7685f55b8 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220913 |
| 141f439e-078c-4a59-acff-ebf7685f55b8 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220913 |
| 141f439e-078c-4a59-acff-ebf7685f55b8 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220913 |
| 151b948a-3106-497a-b1c7-479307faeb89 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 2 | Fulvestrant Injection | 20220826 |
| 151b948a-3106-497a-b1c7-479307faeb89 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 2 | Fulvestrant Injection | 20220826 |
| 151b948a-3106-497a-b1c7-479307faeb89 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 2 | Fulvestrant Injection | 20220826 |
| 477098a1-cd37-48ad-b17f-aef610cb0f57 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220726 |
| 477098a1-cd37-48ad-b17f-aef610cb0f57 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220726 |
| 477098a1-cd37-48ad-b17f-aef610cb0f57 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 2 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20220726 |
| d5ae9e07-73b0-4063-a9e4-0ffc5614c2b8 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20260305 |
| d5ae9e07-73b0-4063-a9e4-0ffc5614c2b8 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20260305 |
| d5ae9e07-73b0-4063-a9e4-0ffc5614c2b8 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20260305 |
| a51aa693-b433-4b2d-a71b-9ba029b10ce3 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250430 |
| a51aa693-b433-4b2d-a71b-9ba029b10ce3 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250430 |
| a51aa693-b433-4b2d-a71b-9ba029b10ce3 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20250430 |
| 0f05b699-c440-42c1-9557-46759a10ab17 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240322 |
| 0f05b699-c440-42c1-9557-46759a10ab17 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240322 |
| 0f05b699-c440-42c1-9557-46759a10ab17 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT INJECTION, for intramuscular use Initial U.S. Approval: 2002 | 20240322 |
| f44cffcc-8f5e-4a4c-a36e-ab946ce86266 | fulvestrant 250 MG in 5 ML Prefilled Syringe | PSN | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240228 |
| f44cffcc-8f5e-4a4c-a36e-ab946ce86266 | 5 ML fulvestrant 50 MG/ML Prefilled Syringe | SCD | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240228 |
| f44cffcc-8f5e-4a4c-a36e-ab946ce86266 | fulvestrant 250 MG per 5 ML Prefilled Syringe | SY | 1 | These highlights do not include all the information needed to use FULVESTRANT INJECTION safely and effectively. See full prescribing information for FULVESTRANT INJECTION. FULVESTRANT injection, for intramuscular use Initial U.S. Approval: 2002 | 20240228 |